Enfuvirtide for Prophylaxis against HIV Infection [3] (multiple letters)

New England Journal of Medicine

Volumn 349, Issue 22, 2003, Pages 2169-2170

  Cuzin, Lise ^a   Alvarez, Muriel ^a   Ferranti, Simone ^b   Menichetti, Francesco ^b  

^a CHU PURPAN   (France)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENFUVIRTIDE;

BLOOD VOLUME; DISEASE TRANSMISSION; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SIDE EFFECT; VIRUS LOAD; VIRUS RESISTANCE;

COST-BENEFIT ANALYSIS; DRUG RESISTANCE; HIV ENVELOPE PROTEIN GP41; HIV FUSION INHIBITORS; HIV INFECTIONS; HIV-1; HUMANS; PEPTIDE FRAGMENTS;

EID: 0344851786     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200311273492218     Document Type: Letter

References (0)